Coyote is an innovative diagnostic company who provides in vitro diagnostic solutions with a special purpose: molecular diagnostics for everyone. Our values and expectations are at the heart of everything we do and form an important part of our culture.
Our strategy is to bring differentiated and high-quality in vitro diagnostic solutions to our customers at the point where it is most needed. Our proprietary and patented FlashDetect technology enables a 30-minute sample-to-result turn-around time using the industry gold-standard quantitative real-time PCR platform.
Our FlashDetect platform technology achieves this by reducing what is conventionally an 8-step process into a 2-step process by removing the need for complex sample preparation required for conventional qPCR assays.
Our product portfolio encompasses point-of-care diagnostics solutions for healthcare providers, hospitals and pathology service providers. In response to the global SARS-CoV-2 pandemic, we have adapted our technologies into read-to-use portable systems for use in non-clinical settings such as customs, checkpoints, airports, etc and into all-in-one mobile laboratories for higher-throughput testing needs such as major sporting events.
We are a rapidly expanding company with a deep commitment to innovation.